1.6-Shogaol, an Active Ingredient of Ginger, Improves Intestinal and Brain Abnormalities in Proteus Mirabilis-Induced Parkinson’s Disease Mouse Model
Eugene HUH ; Jin Gyu CHOI ; Yujin CHOI ; In Gyoung JU ; Dongjin NOH ; Dong-yun SHIN ; Dong Hyun KIM ; Hi-Joon PARK ; Myung Sook OH
Biomolecules & Therapeutics 2023;31(4):417-424
Parkinson’s disease (PD) which has various pathological mechanisms, recently, it is attracting attention to the mechanism via microbiome-gut-brain axis. 6-Shogaol, a representative compound of ginger, have been known for improving PD phenotypes by reducing neuroinflammatory responses. In the present study, we investigated whether 6-shogaol and ginger attenuate degeneration induced by Proteus Mirabilis(P. mirabilis) on the intestine and brain, simultaneously. C57BL/6J mice received P. mirabilis for 5 days. Ginger (300 mg/kg) and 6-shogaol (10 mg/kg) were treated by gavage feeding for 22 days including the period of P. mirabilis treatment. Results showed that 6-shogaol and ginger improved motor dysfunction and dopaminergic neuronal death induced by P. mirabilis treatment. In addition, they suppressed P. mirabilis-induced intestinal barrier disruption, pro-inflammatory signals such as toll-like receptor and TNF-α, and intestinal α-synuclein aggregation. Moreover, ginger and 6-shogaol significantly inhibited neuroinflammation and α-synuclein in the brain. Taken together, 6-shogaol and ginger have the potential to ameliorate PD-like motor behavior and degeneration of dopaminergic neurons induced by P. mirabilis in mice. Here, these findings are meaningful in that they provide the first experimental evidence that 6-shogaol might attenuate PD via regulating gut-brain axis.
2.Utility of shear wave elastography to detect papillary thyroid carcinoma in thyroid nodules: efficacy of the standard deviation elasticity
Hye Jeong KIM ; Mi Kyung KWAK ; In Ho CHOI ; So Young JIN ; Hyeong Kyu PARK ; Dong Won BYUN ; Kyoil SUH ; Myung Hi YOO
The Korean Journal of Internal Medicine 2019;34(4):850-857
BACKGROUND/AIMS:
The aim of this study was to address the role of the elasticity index as a possible predictive marker for detecting papillary thyroid carcinoma (PTC) and quantitatively assess shear wave elastography (SWE) as a tool for differentiating PTC from benign thyroid nodules.
METHODS:
One hundred and nineteen patients with thyroid nodules undergoing SWE before ultrasound-guided fine needle aspiration and core needle biopsy were analyzed. The mean (E(Mean)), minimum (E(Min)), maximum (E(Max)), and standard deviation (E(SD)) of SWE elasticity indices were measured.
RESULTS:
Among 105 nodules, 14 were PTC and 91 were benign. The E(Mean), E(Min), and E(Max) values were significantly higher in PTCs than benign nodules (E(Mean) 37.4 in PTC vs. 23.7 in benign nodules, p = 0.005; E(Min) 27.9 vs. 17.8, p = 0.034; E(Max) 46.7 vs. 31.5, p < 0.001). The E(Mean), E(Min), and E(Max) were significantly associated with PTC with diagnostic odds ratios varying from 6.74 to 9.91, high specificities (86.4%, 86.4%, and 88.1%, respectively), and positive likelihood ratios (4.21, 3.69, and 4.82, respectively). The E(SD) values were significantly higher in PTC than in benign nodules (6.3 vs. 2.6, p < 0.001). E(SD) had the highest specificity (96.6%) when applied with a cut-off value of 6.5 kPa. It had a positive likelihood ratio of 14.75 and a diagnostic odds ratio of 28.50.
CONCLUSIONS
The shear elasticity index of E(SD), with higher likelihood ratios for PTC, will probably identify nodules that have a high potential for malignancy. It may help to identify and select malignant nodules, while reducing unnecessary fine needle aspiration and core needle biopsies of benign nodules.
3.The Incidence and Clinical Characteristics of Acute Serum Creatinine Elevation more than 1.5 mg/dL among the Patients Treated with Tenofovir/Emtricitabine-containing HAART Regimens.
Sun JIN ; Myung Hi KIM ; Jung Hwa PARK ; Hye Jin JUNG ; Hye Jin LEE ; Shin Woo KIM ; Jong Myung LEE ; Sujeong KIM ; Hyun Ha CHANG
Infection and Chemotherapy 2015;47(4):239-246
BACKGROUND: The combination of tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) has been the first choice nucleoside reverse transcriptase inhibitor (NRTI) according to many reliable antiretroviral treatment (ART) guidelines because of its high efficacy. However, TDF-related renal toxicity reported in Western countries is a challenging issue regarding clinical use. We conducted this study to evaluate the incidence and characteristics of an acute increase in serum creatinine (Cr) level > 1.5 mg/dL among TDF/FTC-based highly active antiretroviral treatment (HAART)-treated patients. MATERIALS AND METHODS: We retrospectively reviewed the medical records of 205 HIV-infected patients treated with TDF/FTC-containing regimens between 1 February 2010 and 30 April 2014. Three groups of TDF/FTC + ritonavir-boosted protease inhibitor (PI/r), TDF/FTC + non-nucleoside reverse transcriptase inhibitor (NNRTI), and TDF/FTC + integrase strand transfer inhibitor (INSTI), and three PI/r subgroups of TDF/FTC + lopinavir (LPV)/r, TDF/FTC + atazanavir (ATV)/r, TDF/FTC + darunavir (DRV)/r were evaluated. RESULTS: A total 136 patients (91 in the TDF/FTC + PI/r group, 20 in the TDF/FTC + NNRTI group and 25 in the TDF/FTC + INSTI group) were included in the statistical analysis. Four cases (4.9%; all in the TDF/FTC + PI/r group) among 136 patients showed an acute increase in serum Cr more than 1.5 mg/dL, so the overall incidence was 2.8 cases per 100 patient-years. One case was a patient treated with TDF/FTC + LPV/r, and the others were treated with TDF/FTC + ATV/r. No case of an acute increase in serum Cr was observed in the TDF/FTC + DRV/r group. The incidence of serum Cr increase more than 1.5 mg/dL in TDF/FTC + PI/r group was 4.0 cases per 100 patient-years. CONCLUSION: Although only a small number of patients were evaluated retrospectively from a single center, the TDF/FTC + PI/r regimen may have been related with relatively higher tendency of increment of serum Cr level. These findings reinforce the importance of close follow-ups of HIV-infected patients treated with the TDF/FTC + PI/r regimens.
Anti-Retroviral Agents
;
Antiretroviral Therapy, Highly Active*
;
Atazanavir Sulfate
;
Creatinine*
;
Darunavir
;
Emtricitabine
;
Follow-Up Studies
;
HIV
;
Humans
;
Incidence*
;
Integrases
;
Lopinavir
;
Medical Records
;
Protease Inhibitors
;
Retrospective Studies
;
RNA-Directed DNA Polymerase
;
Tenofovir
4.Consideration of Discrepancy between Needle-Washout Thyroglobulin and Serum Thyroglobulin of Recurrent Papillary Thyroid Cancer.
So Ra KIM ; Mi Kyung KWAK ; Hye Ran KANG ; Seug Yun YOON ; Seong Soon KWON ; Bo Young KIM ; Hoo Nam CHOI ; Hye Jeong KIM ; Jae Wook KIM ; So Young JIN ; Hyeong Kyu PARK ; Dong Won BYUN ; Kyoil SUH ; Myung Hi YOO
Soonchunhyang Medical Science 2014;20(2):123-127
Although the prognosis of papillary thyroid cancer (PTC) is extremely good, locoregional recurrences after initial treatment occur. Thyroglobulin (Tg) is a reliable tumor marker to detect recurrence or persistence of PTC. However, occasionally serum Tg may miss the detection of a recurrence. We report a 54-year-old female presented with hoarseness due to cervical recurrence without concomitant elevation of serum Tg and anti-Tg antibody, in contrast to extremely increased needle-washout Tg, who had undergone a total thyroidectomy and radioiodine ablation as initial therapies for PTC. Several factors causing such discrepancy between needle-washout Tg and serum Tg can be suggested including site of recurrence, volume of tumor, interference by some kind of plasma antibodies other than anti-Tg antibody, and any conformational defect of Tg protein. Among them, the most convincing explanation is that any conformational defect of Tg may lead to impaired secretion of Tg to blood. We suggest that more studies are needed to find the cause for potential mechanisms involved in PTC recurrences without increased serum Tg.
Antibodies
;
Female
;
Hoarseness
;
Humans
;
Middle Aged
;
Plasma
;
Prognosis
;
Recurrence
;
Thyroglobulin*
;
Thyroid Neoplasms*
;
Thyroidectomy
5.Endoscopic comparison of alendronate alone and the enteric-coated alendronate with calcitriol combination in postmenopausal Korean females.
Ji Oh MOK ; Chan Hee JUNG ; Chul Hee KIM ; Chang Beom RYU ; Yeo Joo KIM ; Sang Jin KIM ; Hyeong Kyu PARK ; Kyo Il SUH ; Myung Hi YOO ; Dong Won BYUN
The Korean Journal of Internal Medicine 2013;28(6):694-700
BACKGROUND/AIMS: This study was performed to compare the mucosal findings after esophagogastroduodenoscopy in two groups before and after the use of alendronate only and following administration of the enteric-coated alendronate (5 mg) and calcitriol (0.5 microg) combined drug (Maxmarvil, Yuyu Co.). METHODS: The study population consisted of 33 postmenopausal healthy female volunteers, aged 50 to 70 years (mean age, 58 +/- 5) without gastrointestinal symptoms and with normal baseline endoscopic findings. Esophagogastroduodenoscopy was performed at baseline and was repeated 2 weeks later after daily intake of Maxmarvil (n = 17 subjects) or alendronate only (n = 16 subjects). Mucosal injury scores were reported by an endoscopist after 2 weeks of treatment with each medication schedule. RESULTS: Esophageal mucosal injuries developed in two of 16 subjects in the alendronate only group and 0 of 17 in the Maxmarvil group. Gastric mucosal injuries developed in eight subjects in the alendronate group and four subjects in the Maxmarvil group; this difference was statistically significant. CONCLUSIONS: The mucosal damage scores for the alendronate group (total score 24) were significantly higher than those for the Maxmarvil group (total score 9) in the esophagus and stomach. Therefore, this study suggested that enteric-coated Maxmarvil is less harmful to gastrointestinal mucosa than alendronate, and may improve the tolerability of osteoporosis medication in clinical practice.
Administration, Oral
;
Age Factors
;
Aged
;
Alendronate/administration & dosage/*adverse effects
;
Bone Density Conservation Agents/administration & dosage/*adverse effects
;
Calcitriol/administration & dosage/*adverse effects
;
Drug Combinations
;
*Endoscopy, Digestive System
;
Esophagus/*drug effects/pathology
;
Female
;
Gastric Mucosa/*drug effects/pathology
;
Humans
;
Middle Aged
;
*Postmenopause
;
Predictive Value of Tests
;
Republic of Korea
;
Sex Factors
;
Tablets, Enteric-Coated
;
Time Factors
;
Treatment Outcome
;
Vitamins/administration & dosage/*adverse effects
6.DNA Methylation of RUNX3 in Papillary Thyroid Cancer.
Hee Ja KO ; Bo Yeon KIM ; Chan Hee JUNG ; Sung Wan CHUN ; Ji Oh MOK ; Yeo Joo KIM ; Hyeong Kyu PARK ; Chul Hee KIM ; Sang Jin KIM ; Dong Won BYUN ; Kyo Il SUH ; Myung Hi YOO ; Sung Gu KANG
The Korean Journal of Internal Medicine 2012;27(4):407-410
BACKGROUND/AIMS: The relationship between Runt-related transcription factor 3 (RUNX3) gene inactivation and various solid tumors has been reported; however, little information is available about RUNX3 in thyroid cancers. METHODS: We evaluated the DNA methylation of RUNX3 in 13 papillary thyroid cancer tissues and four thyroid cancer cell lines. Additionally, using reverse transcriptase-polymerase chain reaction, we analyzed RUNX3 gene expression in several thyroid cancer cell lines after treating with the demethylating agent 5-aza-2'-deoxycytidine (DAC). RESULTS: RUNX3 was hypermethylated in many thyroid cancer cell lines and in 10 of the 12 papillary thyroid cancer tissues. Treatment with DAC increased the expression of RUNX3 in some thyroid cancer cell lines. CONCLUSIONS: We suggest that RUNX3 is associated with thyroid carcinogenesis, and RUNX3 methylation is a potentially useful diagnostic marker for papillary thyroid cancer.
Azacitidine/analogs & derivatives/pharmacology
;
Carcinoma/*genetics
;
Cell Line, Tumor
;
Core Binding Factor Alpha 3 Subunit/*genetics
;
DNA Methylation/drug effects
;
Gene Expression/drug effects
;
Humans
;
Thyroid Neoplasms/*genetics
;
Tumor Markers, Biological/genetics
7.A Case of Hypothyroxinemia with Thyroxine-Binding-Globulin Deficiency.
Soon Mi HUR ; Shin Hee KIM ; Min Jin KIM ; Dong Won BYUN ; Kyo Il SUH ; Myung Hi YOO ; Hyeong Kyu PARK
Soonchunhyang Medical Science 2011;17(2):161-163
The transport proteins such as thyroxine-binding-globulin (TBG), albumin and transthyretin carry over 99% of circulating thyroid hormones. TBG is a major thyroid hormone transport protein in serum. Although TBG deficiency does not have metabolic consequences, it has diagnostic implications as it can lead to an incorrect interpretation of thyroid function tests. We experienced a case that a man who had an abnormal thyroid function showed unexpectedly low concentrations of serum total thyroxine. We detected the low TBG in his serum and he was diagnosed the TBG deficiency. We report this case along with a review of the related literature.
Carrier Proteins
;
Prealbumin
;
Thyroid Function Tests
;
Thyroid Gland
;
Thyroid Hormones
;
Thyroxine
8.A Case of Residual Medullary Thyroid Carcinoma Detected by 18F-FDG-PET/CT in Patient with Persistent Hypercalcitoninemia.
Ji Yon KIM ; Dong Won BYUN ; Kyo Il SEO ; So Young JIN ; Myung Hi YOO
Endocrinology and Metabolism 2010;25(4):365-369
Medullary thyroid carcinoma (MTC) is a rare and challenging malignancy. In patients with residual MTC, the tumor detection rate is generally low for most of the currently available imaging techniques. Various imaging methods have already been used for the detection of residual tumor, but no modality has been shown to be superior to others. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) has recently been proposed to identify residual MTC, but this procedure also has limitations as small masses are rarely detected. So, a multimodality imaging approach is recommended for detecting residual MTC. We report here on a case of residual MTC that was detected by 18F-FDG PET/CT in a patient with persistent hypercalcitoninemia after total thyroidectomy and bilateral lymph node dissection.
Calcitonin
;
Electrons
;
Fluorodeoxyglucose F18
;
Humans
;
Lymph Node Excision
;
Neoplasm, Residual
;
Positron-Emission Tomography
;
Thyroid Gland
;
Thyroid Neoplasms
;
Thyroidectomy
9.Reference Values for the Augmentation Index and Pulse Pressure in Apparently Healthy Korean Subjects.
Jin Wook CHUNG ; Young Soo LEE ; Jeong Hyun KIM ; Myung Jun SEONG ; So Yeon KIM ; Jin Bae LEE ; Jae Kean RYU ; Ji Yong CHOI ; Kee Sik KIM ; Sung Gug CHANG ; Geon Ho LEE ; Sung Hi KIM
Korean Circulation Journal 2010;40(4):165-171
BACKGROUND AND OBJECTIVES: Arterial stiffness is a precursor to premature cardiovascular disease. The augmentation index (AI) and pulse pressure (PP) are cardiovascular risk factors. The aim of this study was to define the diagnostic values of the AI and PP from the peripheral arterial and central aortic waveforms in healthy subjects. SUBJECTS AND METHODS: We recruited 522 consecutive subjects (mean age 46.3+/-9.6 years, 290 males) who came to our facility for a comprehensive medical testing. We measured the body mass index (BMI), blood pressure, peripheral and central PP, and a pulse wave analysis that included the central and peripheral AI. RESULTS: The peripheral and central AIs in the female subjects were significantly higher than that in the male subjects (p<0.001). The peripheral and central PPs in the subjects with hyperlipidemia were significantly higher than subjects with normal lipid profiles (p<0.001). The peripheral and central PPs and peripheral and central AIs significantly increased with age. CONCLUSION: Pending validation in prospective outcome-based studies, a peripheral PP of 70 mmHg, central PP of 50 mmHg, peripheral AI of 100%, and central AI of 40% may be preliminary values in adult subjects.
Adult
;
Arteries
;
Blood Pressure
;
Body Mass Index
;
Cardiovascular Diseases
;
Female
;
Humans
;
Hyperlipidemias
;
Male
;
Porphyrins
;
Prospective Studies
;
Pulse Wave Analysis
;
Reference Values
;
Risk Factors
;
Vascular Stiffness
10.Health Behaviors, Reproductive Health History, and Sexual Behaviors of College Students.
Sukhee AHN ; Insook PARK ; Jin Sook HAN ; Tae Im KIM ; Myung Soon KWAK ; Hi Sook CHUNG
Korean Journal of Women Health Nursing 2008;14(3):205-212
PURPOSE: The purpose of this study was to survey the health behaviors related to reproductive health, reproductive health history, and sexual behaviors of college students in local areas. METHOD: With a survey design, 792 college students from C and D areas were recruited to assess health behaviors such as smoking and alcohol drinking, as well as history of reproductive health and sexual behaviors. The data were collected by a self-administered questionnaire from November to December, 2007. RESULT: Mean age of the students was 20.8(SD=1.96) and gender distribution was 29.2% for male and 70.8% for female. Unhealthy behaviors were alcohol drinking, smoking, excessive weight loss, and irregular exercise; unsafe sex practices were experience of sexual intercourse with multiple sex partners and history of sexually transmitted disease (STD). Male students had more alcohol drinking (p=.04), smoking(p<.001), excessive weight loss(p=.01), experience of sexual intercourse with multiple sex partners(p<.001), history of STD(p=.025) compared to females. On the other hands, female students participated in regular exercise less than males(p<.001). CONCLUSION: College students seem to perform unhealthy behaviors related to reproductive health and less effective way of safe sex practices. Therefore, a planned education program for reproductive health promotion operated by college level is needed to assess and improve the level of reproductive health in college students.
Alcohol Drinking
;
Coitus
;
Female
;
Hand
;
Health Behavior
;
Humans
;
Male
;
Surveys and Questionnaires
;
Reproductive Health
;
Safe Sex
;
Sexual Behavior
;
Sexually Transmitted Diseases
;
Smoke
;
Smoking
;
Unsafe Sex
;
Weight Loss

Result Analysis
Print
Save
E-mail